SSY GROUP (02005) has obtained the drug production registration certificate for the sodium bicarbonate injection solution in ampoules (10ml: 0.84g) related to the State Food and Drug Administration.
Shi Si Pharmaceutical Group (02005) released an announcement that the group has obtained the relevant approval from the China National Medical Products Administration regarding ampoule packaging...
SSY GROUP (02005) announced that the group has obtained the drug production registration certificate for sodium hydrogen carbonate injection in ampoule packaging (10ml: 0.84g) from the China National Medical Products Administration. This drug belongs to the category 3 of chemical drugs and is considered to have passed consistency evaluation.
Sodium hydrogen carbonate injection in ampoule packaging is mainly used to treat metabolic acidosis, alkalinization of urine, and intravenous infusion for poisoning by certain drugs.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
